Amphastar Pharmaceuticals, Inc. Quarterly Cost of Revenue in USD from Q2 2013 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Amphastar Pharmaceuticals, Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2013 to Q4 2024.
  • Amphastar Pharmaceuticals, Inc. Cost of Revenue for the quarter ending December 31, 2024 was $99.9M, a 21.9% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. Cost of Revenue for the twelve months ending December 31, 2024 was $358M, a 22.1% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. annual Cost of Revenue for 2024 was $358M, a 22.1% increase from 2023.
  • Amphastar Pharmaceuticals, Inc. annual Cost of Revenue for 2023 was $293M, a 17.3% increase from 2022.
  • Amphastar Pharmaceuticals, Inc. annual Cost of Revenue for 2022 was $250M, a 5.08% increase from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $358M $99.9M +$17.9M +21.9% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-03
Q3 2024 $340M $89.3M +$17.1M +23.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $323M $87.2M +$14.3M +19.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $309M $81.7M +$15.6M +23.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $293M $82M +$18.1M +28.4% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-03
Q3 2023 $275M $72.2M +$10.5M +17.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $265M $73M +$12.9M +21.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $252M $66.2M +$1.64M +2.54% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $250M $63.9M -$798K -1.23% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-03
Q3 2022 $251M $61.6M +$604K +0.99% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $250M $60.1M +$5.82M +10.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $244M $64.5M +$6.47M +11.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $238M $64.7M +$5.56M +9.42% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $232M $61M +$14.1M +30% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $218M $54.3M +$1.66M +3.15% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $217M $58.1M +$10.2M +21.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $207M $59.1M +$9.09M +18.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $197M $46.9M +$2.04M +4.54% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $195M $52.6M +$5.97M +12.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $189M $47.9M -$1.02M -2.09% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $190M $50M -$5M -9.09% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-11
Q3 2019 $195M $44.9M -$1.4M -3.02% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $197M $46.7M +$1.68M +3.74% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $195M $48.9M +$7.47M +18% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $188M $55M +$15M +37.4% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-15
Q3 2018 $173M $46.3M +$8.92M +23.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $164M $45M +$6.54M +17% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $157M $41.4M +$7.58M +22.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $150M $40M -$3.55M -8.16% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-16
Q3 2017 $153M $37.4M +$752K +2.05% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $152M $38.4M +$2.12M +5.84% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $150M $33.8M -$622K -1.81% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $151M $43.6M -$166K -0.38% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-15
Q3 2016 $151M $36.6M -$9.68M -20.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $161M $36.3M -$4.22M -10.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $165M $34.5M -$9.14M -21% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $174M $43.7M -$175K -0.4% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-14
Q3 2015 $174M $46.3M -$1.63M -3.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $176M $40.5M +$6.53M +19.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $169M $43.6M +$10.2M +30.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $159M $43.9M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 $47.9M +$8.88M +22.8% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 $34M -$1.03M -2.93% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $33.4M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q3 2013 $39M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $35M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.